| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Anaptysbio, Inc. (ANAB) has 13 insiders with recent SEC Form 4 filings, including 10 buys and 13 sells. ANAB is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 506.9K | $26.17M | - | |
| Other | 42.1K | $2.17M | - | |
| Dir | 39.7K | $2.05M | - | |
| CFO | 25.8K | $1.33M | - | |
| CFO | 21.9K | $1.13M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 4, 2021 | Ecor1 Capital, LLC75 | Director, 10% Owner | Buy | 221,500 | $23.24 | $5,147,443.53 | +1.0% | +0.0% | +3.5% | |
| Apr 27, 2021 | Ecor1 Capital, LLC75 | Director, 10% Owner | Buy | 147,300 | $23.63 | $3,480,233.08 | +0.7% | +0.8% | -5.9% | |
| Mar 9, 2021 | Ecor1 Capital, LLC75 | 10% Owner | Buy | 3,308,800 | $18.93 | $62,622,736.04 | +31.6% | +24.8% | +62.9% | |
| Feb 23, 2021 | Ecor1 Capital, LLC75 | 10% Owner | Buy | 29,500 | $25.48 | $751,657.05 | +0.8% | -7.6% | +12.1% | |
| Feb 12, 2021 | Loumeau Eric J61 | COO, General Counsel | Sale+OE | 10,000 | $35.00 | $350,000.00 | -100% | -26.3% | -14.9% | |
| Dec 10, 2019 | Ware J. Anthony | Director | Buy | 3,600 | $14.05 | $50,580.00 | New | - | - | |
| Jun 10, 2019 | Suria Hamza68 | President, CEO | Sell | 22,428 | $73.76 | $1,654,349.96 | -16.6% | - | - | |
| Jun 4, 2019 | Londei Marco | Chief Medical Officer | Sale+OE | 10,060 | $73.06 | $734,961.57 | -12.1% | - | - | |
| Jan 15, 2019 | Londei Marco | Chief Medical Officer | Sale+OE | 19,075 | $69.88 | $1,332,881.56 | -24.2% | - | - | |
| Jan 14, 2019 | Suria Hamza68 | President, CEO | Sale+OE | 40,000 | $70.79 | $2,831,531.74 | -35.6% | - | - |